EUVIMEDEUVIMED entdecken
Crossref

Receipt survey of prescription continuation rates for patients with onychomycosis and web‐based survey of dermatologists on prescribing policies for onychomycosis therapeutics

Yuichiro Tsunemi iD, Atsushi Otsuka iD, Yusuke Nonaka iD

The Journal of Dermatology · 2024

DOI: 10.1111/1346-8138.17110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, 2024. Verfasst von Yuichiro Tsunemi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Saitama Medical University, Saitama, Japan. Hauptthemen laut MEDLINE: Onychomycosis, Foot Dermatoses. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Gefördert von: Sato Pharmaceutical, Eisai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Onychomycosis can be treated with topical and oral medications. However, it is important to appropriately select these medications according to the type and severity of the disease and ensure treatment is continued for the recommended duration. In Japan, treatment options for onychomycosis have increased in recent years. Moreover, in 2019, the guidelines for dermatomycosis treatment were revised. In this study, we conducted a receipt survey to clarify the actual treatment status of onychomycosis cases as indicated by the continuation rates of prescribed treatment drugs, together with a web‐based survey to ascertain the prescribing policy of dermatologists regarding drugs for onychomycosis treatment. In agreement with past surveys, this receipt survey showed that the prescription continuation rate for oral medications was higher than that for topical medications. The 1‐year prescription continuation rate for topical onychomycosis medications was found to be low (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OnychomycosisFoot DermatosesHumansAntifungal AgentsDermatologistsAdministration, OralInternetAdministration, Topical

Stichwörter der Autor:innen

continuation ratefosravuconazoleonychomycosissurveytreatment

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Department of Dermatology, Saitama Medical University, Saitama, Japan.
  • Department of Dermatology, Faculty of Medicine, Kindai University, Osaka, Japan.
  • Medical Affairs Department, Sato Pharmaceutical Co., Ltd., Tokyo, Japan.

ORCID-Profile: Yuichiro Tsunemi, Atsushi Otsuka, Yusuke Nonaka

Förderung

  • Sato Pharmaceutical
  • Eisai

Zitieren

APA

Tsunemi, Y., Otsuka, A., & Nonaka, Y. (2024). Receipt survey of prescription continuation rates for patients with onychomycosis and web‐based survey of dermatologists on prescribing policies for onychomycosis therapeutics. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17110

Vancouver

Tsunemi Y, Otsuka A, Nonaka Y. Receipt survey of prescription continuation rates for patients with onychomycosis and web‐based survey of dermatologists on prescribing policies for onychomycosis therapeutics. The Journal of Dermatology. 2024. doi:10.1111/1346-8138.17110

BibTeX
@article{Tsunemi2024,
  author = {Tsunemi, Yuichiro and Otsuka, Atsushi and Nonaka, Yusuke},
  title = {Receipt survey of prescription continuation rates for patients with onychomycosis and web‐based survey of dermatologists on prescribing policies for onychomycosis therapeutics},
  journal = {The Journal of Dermatology},
  year = {2024},
  doi = {10.1111/1346-8138.17110}
}
Kostenlos starten →